11:23 AM
Jan 17, 2018
 |  BC Innovations  |  Distillery Therapeutics


INDICATION: Gastric cancer

Patient sample and mouse studies suggest inhibiting PYCARD or its downstream effector IL-18 could help treat gastric cancer. In tumor samples from patients, levels of PYCARD and IL-18 were higher than in matched normal tissue. In a mouse model of gastric cancer,...

Read the full 196 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$35 USD
More Info >